Ehave is a healthcare company dedicated to developing innovative digital solutions for the medical cannabis and mental health sectors. With its health informatics platform, the company effectively captures high-quality, objective user data, addressing the information gap in healthcare. Ehave aims to empower users and enhance patient care through the deployment of novel digital assessment and remediation tools. Specifically focused on the medical cannabis industry and mental health, Ehave believes that these sectors will greatly benefit from improved data collection and analysis.
Founded in 2012 and headquartered in Canada, Ehave is recognized as the leading provider of digital therapeutics for the psychedelic and mental health sectors, with the potential to drive significant impact in the healthcare industry. As the company continues to innovate and expand its reach, the potential for future investments and collaborations with key investors remains an area of interest and opportunity.